A Phase 2 Study of Marqibo in Patients With Metastatic Uveal Melanoma
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2015
At a glance
- Drugs Vincristine (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Spectrum Pharmaceuticals; Talon Therapeutics
- 03 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Dec 2013 Planned end date changed from 1 Jul 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 16 Jan 2013 Planned end date changed from 1 Mar 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.